BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29105142)

  • 1. The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines.
    Bahi M; Walmsley RS; Gray AR; Young D; Hobbs CE; Aluzaite K; Schultz M
    J Gastroenterol Hepatol; 2018 May; 33(5):1047-1052. PubMed ID: 29105142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
    Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
    JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy.
    Selinger CP; Rosiou K; Broglio G; Lever G; Chiu CM; Stocker LJ; Chipeta H; Glanville T
    Expert Opin Drug Saf; 2023; 22(11):1091-1097. PubMed ID: 37417244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
    Kobayashi T; Uda A; Udagawa E; Hibi T
    J Crohns Colitis; 2020 Jun; 14(5):617-623. PubMed ID: 31867632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.
    Calafat M; Mañosa M; Mesonero F; Guardiola J; Mínguez M; Nos P; Vera I; Taxonera C; Iglesias E; Ricart E; Gisbert JP; Calvet X; García-López S; Monfort D; Pérez Calle JL; Riestra S; Gomollón F; Garcia-Planella E; Bermejo F; Hernández V; Martín-Arranz MD; Gutiérrez A; Torres P; Cañete F; Domènech E;
    J Crohns Colitis; 2020 Sep; 14(9):1290-1298. PubMed ID: 32201893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmelanoma skin cancer in inflammatory bowel disease: a review.
    Long MD; Kappelman MD; Pipkin CA
    Inflamm Bowel Dis; 2011 Jun; 17(6):1423-7. PubMed ID: 21053358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control study.
    Jansen FM; den Broeder N; Lubeek SFK; Savelkoul EHJ; Marcus CM; Hoentjen F; van Dop WA
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1123-1130. PubMed ID: 37665613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD.
    Yeaman F; Stritzke A; Kuret V; Sharifi N; Seow CH; Metcalfe A; Leung Y
    Crohns Colitis 360; 2023 Oct; 5(4):otad066. PubMed ID: 37941596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.
    Guerra I; Barros F; Chaparro M; Benítez JM; Martín-Arranz MD; de Francisco R; Piqueras M; de Castro L; Carbajo AY; Bermejo F; Mínguez M; Gutiérrez A; Mesonero F; Cañete F; González-Muñoza C; Calvo M; Sicilia B; Alfambra E; Rivero M; Lucendo AJ; Tardillo CA; Almela P; Bujanda L; van Domselaar M; Ramos L; Fernández Sánchez M; Hinojosa E; Verdejo C; Gimenez A; Rodríguez-Lago I; Manceñido N; Pérez Calle JL; Moreno MDP; Delgado-Guillena PG; Antolín B; Ramírez de la Piscina P; Casanova MJ; Soto Escribano P; Martín Arranz E; Pérez-Martínez I; Mena R; García Morales N; Granja A; Boscá Watts MM; Francés R; Fernández C; Calafat M; Roig-Ramos C; Vera MI; Carracedo Á; Domènech E; Gisbert JP;
    Dig Dis; 2024; 42(3):257-264. PubMed ID: 38452742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrus Consumption and Risk of Non-Melanoma Skin Cancer in the UK Biobank.
    Marley AR; Li M; Champion VL; Song Y; Han J; Li X
    Nutr Cancer; 2022; 74(3):810-815. PubMed ID: 34282681
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of inflammatory bowel disease patients with prior malignancy.
    Shani U; Klang E; Lassman S; Ungar B; Ben-Horin S; Kopylov U
    Ann Gastroenterol; 2023; 36(4):405-411. PubMed ID: 37396000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
    Kim PJ; Lansang RP; Ko E; Abu-Hilal M
    Eur J Dermatol; 2023 Oct; 33(5):506-513. PubMed ID: 38297926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Insulin Use and Social Determinants of Health on Non-melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System.
    Massouh N; Jaffa AA; Jaffa MA
    Cancer Control; 2024; 31():10732748241249896. PubMed ID: 38680117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of sociodemographic risk factors for presentation with advanced non-melanoma skin cancer.
    Bacorn C; Serrano M; Lin LK
    Orbit; 2023 Oct; 42(5):481-486. PubMed ID: 36120852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality associated with non-melanoma skin cancer in Spain from 1979 to 2018: trends and age-adjusted rates.
    Sendín-Martin M; Durán-Romero AJ; Martin-Carrasco P; Conejo-Mir J; Pereyra-Rodriguez JJ
    Eur J Dermatol; 2021 Aug; ():. PubMed ID: 34463287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological trends in skin cancer.
    Apalla Z; Lallas A; Sotiriou E; Lazaridou E; Ioannides D
    Dermatol Pract Concept; 2017 Apr; 7(2):1-6. PubMed ID: 28515985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
    Krönert MIC; Schwarzenböck SM; Kurth J; Heuschkel M; Krause BJ; Emmert S; Tietze JK
    Healthcare (Basel); 2024 Apr; 12(9):. PubMed ID: 38727478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative Flow Cytometry for the Rapid Diagnosis and Validation of Surgical Clearance of Non-Melanoma Skin Cancer: A Prospective Clinical Feasibility Study.
    Markopoulos G; Lampri E; Tragani I; Kourkoumelis N; Vartholomatos G; Seretis K
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good news about melanoma.
    Elwood M; Rademaker M
    N Z Med J; 2024 May; 137(1595):9-12. PubMed ID: 38754110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.